Form FDA 3542 FDA 3542 Patent Declaration After Filing NDA or Supplement

Applications for FDA Approval to Market a New Drug: Patent Listing Requirements and Application of 30-month Stays on Approval of Abbreviated New Drug Applications Certifying That...

Form FDA 3542 Patent Declaration After Filing Exp 2019

Form FDA 3542

OMB: 0910-0513

Document [pdf]
Download: pdf | pdf
Please wait...
If this message is not eventually replaced by the proper contents of the document, your PDF
viewer may not be able to display this type of document.
You can upgrade to the latest version of Adobe Reader for Windows®, Mac, or Linux® by
visiting http://www.adobe.com/go/reader_download.
For more assistance with Adobe Reader visit http://www.adobe.com/go/acrreader.
Windows is either a registered trademark or a trademark of Microsoft Corporation in the United States and/or other countries. Mac is a trademark
of Apple Inc., registered in the United States and other countries. Linux is the registered trademark of Linus Torvalds in the U.S. and other
countries.


File Typeapplication/pdf
File TitleFORM FDA 3542
SubjectPatent Information Submitted Upon and After Approval of an NDA or Supplement for Each Patent That Claims a Drug Substance (Activ
AuthorPSC Publishing Services
File Modified2019-09-10
File Created2016-11-29

© 2024 OMB.report | Privacy Policy